Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
Login | Create an Account

CE Catch UP 2022 (Virtual)


CE Catch Up
Hosted by Alpha Kappa Chapter, Phi Delta Chi, MUSC College of Pharmacy
 
March 19, 2022
9:00 am - 4:30 pm
 
Held Virtually via Microsoft Teams
 
 
Fees: $82.95 - Pharmacist
           $41.55 - Pharmacy Technician 
Credit card payments accepted online*: https://square.link/u/328Eu57h
*A convenience fee of 3.5% will be added to your tuition to cover online payment processing.
Venmo payments accepted:  @pdcalphakappawkf
 
For questions about registration, please contact Samantha Brice – bricesa@musc.edu
 
 
 
9:00 am-
10:00 am
Infectious Diseases Pharmacy 101: What you Really Need to Know about Bacteria and Antibiotics
Taylor Morisette, PharmD, MPH; Assistant Professor, Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina (MUSC) College of Pharmacy; Clinical Pharmacy Specialist, Infectious Diseases and Antimicrobial Stewardship, MUSC Shawn Jenkins Children's Hospital
ACPE UAN 0062-9999-22-029-L01-P/T
(1.0 credit hours, 0.1 CEU; knowledge-based)
 
Learning Objectives:
At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Define, describe, and implement concepts of clinical microbiology, antimicrobial pharmacokinetics/pharmacodynamics, an antibiogram, and antimicrobial susceptibility information
  2. Define general terminology and principles associated with microorganisms and antimicrobials and apply their use in clinical practice
  3. Review specific features of antibiotics, including: drugs within a class, mechanism of action, available routes of administration, pharmacokinetic/pharmacodynamic properties, spectrum-of-activity, adverse effects, monitoring parameters, and patient counseling points
  4. Design antimicrobial regimens to manage common infectious scenarios
10:00 am-10:15 am
Break
10:15 am-
11:15 pm
Acute Pain Management with Pharmacologic Therapies: A Balancing Act 
Emmeline Tran, PharmD, BCPS; Assistant Professor, Medical University of South  Carolina; Charleston, SC
ACPE UAN 0062-9999-22-031-L08-P/T
(1.0 credit hours, 0.1 CEU; application-based)
 
Learning Objectives:
At the conclusion of the program, the pharmacist will be able to:
  1. Define multimodal pain management
  2. Discuss multimodal acute pain management strategies
  3. Given common clinical scenarios, identify and describe limitations of pharmacologic acute pain management strategies
  4. Integrate evidence-based recommendations into clinical practice
At the completion of this activity, the pharmacy technician will be able to:
  1. Define multimodal pain management
  2. Discuss medications used in multimodal acute pain management
  3. Identify challenges in pain management in the acute care setting
11:15 am-11:30 am
Break
11:30 am -
12:30 pm
Just Say No to Nitrosamines and Cigarettes 
Emily Ware, PharmD; Clinical Pharmacy Specialist - Ambulatory Care, Medical University of South Carolina, Charleston, SC
ACPE UAN 0062-9999-22-032-L01-P/T
(1.0 credit hours, 0.1 CEU; application-based)
 
Learning Objectives:
At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Examine the impact of the presence of nitrosamines within pharmaceutical drugs
  2. Describe the risks associated with nitrosamines
  3. Analyze literature regarding the recent recall of varenicline
  4. Discuss therapeutic alternatives to varenicline for tobacco treatment
12:30 pm-
1:00 pm
Lunch
1:00 pm-
3:00 pm
New Drug Update 2021-2022
C. Wayne Weart, PharmD, BCPS, FASHP, FAPhA; Professor, MUSC College of Pharmacy
ACPE UAN 0062-9999-22-033-L01-P/T
(2.0 credit hours, 0.2 CEU; knowledge-based)
 
Learning Objectives:
At the conclusion of the program, the pharmacist will be able to:
  1. Describe the recent changes/recommendation by the CDC for immunizations including zoster vaccine recombinant, PCV-20, PCV-15, and COVID-19 vaccines
  2. Discuss the changes recommended in the 2021 Global Initiative for Asthma (GINA) Guidelines and the 2022 Global Obstructive Lung Disease (GOLD) Guidelines
  3. Describe the changes in the American Heart Association/American College of Cardiology focused update for the treatment of heart failure with reduced ejection fraction and the evidence on which they are based
  4. Describe the Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 and where the new drugs should be considered
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe who should be immunized, based upon the current CDC Guidelines.
  2. Discuss which inhalers should be used for treatment and prevention in patients with asthma and/or COPD
  3. Describe when patients with heart failure should be treated with specific medications
  4. Discuss when and how to use specific lipid lowering medications
3:00 pm-
3:15 pm
Break
3:15 pm-
4:15 pm
A Review of Specialty Pharmacy Therapies for Migraines in Adults
Cole Swanson, PharmD, CDCES; Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy, Charleston, SC
ACPE UAN 0062-9999-22-030-L01-P/T
(1.0 credit hours, 0.1 CEU; application-based)
 
Learning Objectives:
At the conclusion of the program, the pharmacist will be able to:
  1. Define the role of Specialty Pharmacy in the patient care process
  2. Recognize the place in therapy of CGRP-inhibitors used for acute management and prevention of migraines
  3. Recall the storage, dispensing, and safety requirements for specialty migraine medications
At the completion of this activity, the pharmacy technician will be able to:
  1. Utilize copay cards and patient assistance programs to reduce the cost of migraine specialty medications
  2. Recognize the difference between CGRP-inhibitors used for acute management and prevention of migraines
  3. Identify which CGRP-inhibitors are orally administered and which are injectable
4:15 pm-
4:30 pm
Wrap Up and Accessing CE Documentation
 

Date: Mar 19, 2022 09:00 AM - 04:30 PM

CE Hours

6.00

CE Units

0.600

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Phi Delta Chi, Alpha Kappa Chapter, Medical University of South Carolina College of Pharmacy

Requirements for CE Credit

Participants must sign in upon arrival, have attendance verified, attend the program in its entirety, and fully complete the associated online evaluation.  Failure to complete the evaluation within 30 days of attendance may result in loss of credit.  The NABP CPE Monitor will not accept credit submitted greater than 60 days from the date of attendance.
 
Participants must update their accounts to properly reflect their month and day of birth and their correct NABP e-Profile ID.  Failure to do so may result in loss of credit.  Registration with a proper disclosure of your NABP e-Profile ID is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP e-Profile, please click on the CPE Monitor logo below to be directed to their site.

 

 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Define, describe, and implement concepts of clinical microbiology, antimicrobial pharmacokinetics/pharmacodynamics, an antibiogram, and antimicrobial susceptibility information
  2. Define general terminology and principles associated with microorganisms and antimicrobials and apply their use in clinical practice
  3. Review specific features of antibiotics, including: drugs within a class, mechanism of action, available routes of administration, pharmacokinetic/pharmacodynamic properties, spectrum-of-activity, adverse effects, monitoring parameters, and patient counseling points
  4. Design antimicrobial regimens to manage common infectious scenarios

Speaker(s)/Author(s)

Taylor Morrisette, PharmD, MPH
Assistant Professor, Clinical Pharmacy and Outcomes Sciences Medical University of South Carolina (MUSC) College of Pharmacy; Clinical Pharmacy Specialist, Infectious Diseases and Antimicrobial Stewardship MUSC Shawn Jenkins Children's Hospital

Activity Number

0062-9999-22-029-L01-P/T
Date: 03/19/22
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the conclusion of the program, the pharmacist will be able to:
  1. Define multimodal pain management
  2. Discuss multimodal acute pain management strategies
  3. Given common clinical scenarios, identify and describe limitations of pharmacologic acute pain management strategies
  4. Integrate evidence-based recommendations into clinical practice
At the completion of this activity, the pharmacy technician will be able to:
  1. Define multimodal pain management
  2. Discuss medications used in multimodal acute pain management
  3. Identify challenges in pain management in the acute care setting

Speaker(s)/Author(s)

Emmeline Tran, PharmD, BCPS
Assistant Professor, Medical University of South Carolina

Activity Number

0062-9999-22-031-L08-P/T
Date: 03/19/22
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Examine the impact of the presence of nitrosamines within pharmaceutical drugs
  2. Describe the risks associated with nitrosamines
  3. Analyze literature regarding the recent recall of varenicline
  4. Discuss therapeutic alternatives to varenicline for tobacco treatment

Speaker(s)/Author(s)

Emily Ware, PharmD
Clinical Pharmacy Specialist - Ambulatory Care, Medical University of South Carolina

Activity Number

0062-9999-22-032-L01-P/T
Date: 03/19/22
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
 

 

At the conclusion of the program, the pharmacist will be able to:
  1. Describe the recent changes/recommendation by the CDC for immunizations including zoster vaccine recombinant, PCV-20, PCV-15, and COVID-19 vaccines
  2. Discuss the changes recommended in the 2021 Global Initiative for Asthma (GINA) Guidelines and the 2022 Global Obstructive Lung Disease (GOLD) Guidelines
  3. Describe the changes in the American Heart Association/American College of Cardiology focused update for the treatment of heart failure with reduced ejection fraction and the evidence on which they are based
  4. Describe the Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 and where the new drugs should be considered
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe who should be immunized, based upon the current CDC Guidelines.
  2. Discuss which inhalers should be used for treatment and prevention in patients with asthma and/or COPD
  3. Describe when patients with heart failure should be treated with specific medications
  4. Discuss when and how to use specific lipid lowering medications

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, FASHP, FAPhA
Professor Emeritus Department of Clinical Pharmacy and Outcome Sciences and Professor of Family Medicine, MUSC College of Pharmacy

Activity Number

0062-9999-22-033-L01-P/T
Date: 03/19/22
Time: 01:00 PM - 03:00 PM

CE Hours

2.00
 

 

At the conclusion of the program, the pharmacist will be able to:
  1. Define the role of Specialty Pharmacy in the patient care process
  2. Recognize the place in therapy of CGRP-inhibitors used for acute management and prevention of migraines
  3. Recall the storage, dispensing, and safety requirements for specialty migraine medications
At the completion of this activity, the pharmacy technician will be able to:
  1. Utilize copay cards and patient assistance programs to reduce the cost of migraine specialty medications
  2. Recognize the difference between CGRP-inhibitors used for acute management and prevention of migraines
  3. Identify which CGRP-inhibitors are orally administered and which are injectable

Speaker(s)/Author(s)

Cole Swanson, PharmD, CDCES
Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy

Activity Number

0062-9999-22-030-L01-P/T
Date: 03/19/22
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
 



 
University of South Carolina College of Pharmacy | 715 Sumter Street, Coker Life Sciences, Columbia, SC 29208 | 803-777-9979 | CE@cop.sc.edu
 
Powered By: Learning ExpressCE
Copyright © 2024 UofSC College of Pharmacy Continuing Education. All Rights Reserved.
About Us Privacy Policy Terms of Service